Medical Journals

Oral Immunization of Mice Using Transgenic Tomato Fruit Expressing Vp1 Protein from Enterovirus 71.

Authors:
  • Chen Hsuan-Fu
  • Chang Meng-Huei
  • Chiang Bor-Luen
  • Jeng Shih-Tong

From: Institute of Plant Biology and Department of Life Science, National Taiwan University, Taipei, Taiwan, ROC.

Vaccine

  • Publish Date: Apr 2006
  • ISSN: 0264-410X
  • Volume: 24
  • Issue: 15
  • Pages: 2944-51
  • Medium: Print
  • Language: English
  • Citation (JAMA): Chen Hsuan-Fu, Chang Meng-Huei, Chiang Bor-Luen, et al. Oral Immunization of Mice Using Transgenic Tomato Fruit Expressing Vp1 Protein from Enterovirus 71.. Vaccine Apr 2006;24:2944-51

Abstract

Enterovirus 71 (EV71) causes seasonal epidemics of hand-foot-and-mouth disease associated with fatal neurological complications in young children, and several major outbreaks have occurred recently. This study developed an effective antiviral agent by transforming the gene for VP1 protein, a previously defined epitope and also a coat protein of EV71, into tomato plant. VP1 protein was first fused with sorting signals to enable it to be retained in the endoplasmic reticulum of tomato plant, and its expression level increased to 27 microg/g of fresh tomato fruit. Transgenic tomato fruit expressing VP1 protein was then used as an oral vaccine, and the development of VP1-specific fecal IgA and serum IgG were observed in BALB/c mice. Additionally, serum from mice fed transgenic tomato could neutralize the infection of EV71 to rhabdomyosarcoma cells, indicating that tomato fruit expressing VP1 was successful in orally immunizing mice. Moreover, the proliferation of spleen cells from orally immunized mice was stimulated by VP1 protein, and provided further evidence of both humoral and cellular immunity. Results of this study not only demonstrate the feasibility of using transgenic tomato as an oral vaccine to generate protective immunity in mice against EV71, but also suggest the probability of enterovirus vaccine development.

Mesh Headings (Keywords): Administration, Oral, Animals, Antibodies, Viral, Capsid Proteins, Cytokines, Enterovirus, Enzyme-Linked Immunosorbent Assay, Female, Lycopersicon esculentum, Lymphocytes, Mice, Mice, Inbred BALB C, Plants, Genetically Modified, Protein Sorting Signals, Spleen, Vaccines, Edible, Vaccines, Synthetic, Viral Vaccines


Check for Full Text / PubMed Unique Identifier (PMID): 16448730


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.